These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 23269742)

  • 1. Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales.
    Pichon B; Ladhani SN; Slack MP; Segonds-Pichon A; Andrews NJ; Waight PA; Miller E; George R
    J Clin Microbiol; 2013 Mar; 51(3):820-7. PubMed ID: 23269742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods.
    Yildirim I; Stevenson A; Hsu KK; Pelton SI
    Pediatr Infect Dis J; 2012 Oct; 31(10):1016-21. PubMed ID: 22673142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine.
    Elberse KE; van der Heide HG; Witteveen S; van de Pol I; Schot CS; van der Ende A; Berbers GA; Schouls LM
    Vaccine; 2012 Dec; 30(52):7644-51. PubMed ID: 22521844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016.
    Oligbu G; Collins S; Djennad A; Sheppard CL; Fry NK; Andrews NJ; Borrow R; Ramsay ME; Ladhani SN
    Emerg Infect Dis; 2019 Sep; 25(9):1708-1718. PubMed ID: 31441745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany.
    Imöhl M; Möller J; Reinert RR; Perniciaro S; van der Linden M; Aktas O
    BMC Infect Dis; 2015 Feb; 15():61. PubMed ID: 25885764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological and molecular characterization of invasive Streptococcus pneumoniae isolated following introduction of 7-valent conjugate vaccine in Kinki region, Japan, 2008-2013.
    Toda H; Tanaka Y; Satoh K; Komatsu M; Wada Y; Tobe T; Kamisako T
    J Infect Chemother; 2020 May; 26(5):451-458. PubMed ID: 31870586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.
    Hsu HE; Shutt KA; Moore MR; Beall BW; Bennett NM; Craig AS; Farley MM; Jorgensen JH; Lexau CA; Petit S; Reingold A; Schaffner W; Thomas A; Whitney CG; Harrison LH
    N Engl J Med; 2009 Jan; 360(3):244-56. PubMed ID: 19144940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.
    Ampofo K; Pavia AT; Chris S; Hersh AL; Bender JM; Blaschke AJ; Weng HY; Korgenski KE; Daly J; Mason EO; Byington CL
    Pediatr Infect Dis J; 2012 Mar; 31(3):228-34. PubMed ID: 22330164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.
    Foster D; Knox K; Walker AS; Griffiths DT; Moore H; Haworth E; Peto T; Brueggemann AB; Crook DW; On Behalf Of The Oxford Invasive Pneumococcal Surveillance Group
    J Med Microbiol; 2008 Apr; 57(Pt 4):480-487. PubMed ID: 18349369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood Deaths Attributable to Invasive Pneumococcal Disease in England and Wales, 2006-2014.
    Oligbu G; Collins S; Sheppard CL; Fry NK; Slack M; Borrow R; Ladhani SN
    Clin Infect Dis; 2017 Jul; 65(2):308-314. PubMed ID: 28605414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002.
    Beall B; McEllistrem MC; Gertz RE; Wedel S; Boxrud DJ; Gonzalez AL; Medina MJ; Pai R; Thompson TA; Harrison LH; McGee L; Whitney CG;
    J Clin Microbiol; 2006 Mar; 44(3):999-1017. PubMed ID: 16517889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.
    Miller E; Andrews NJ; Waight PA; Slack MP; George RC
    Lancet Infect Dis; 2011 Oct; 11(10):760-8. PubMed ID: 21621466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of invasive pneumococcal isolates from children in Ontario, Canada, 2007-2012.
    Deng X; Arya G; Memari N; Mackenzie R; MacMullin G; Low DE; Pillai DR; Gubbay JB
    Pediatr Infect Dis J; 2015 Jun; 34(6):594-8. PubMed ID: 25831418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
    Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
    Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.
    van der Linden M; Weiß S; Falkenhorst G; Siedler A; Imöhl M; von Kries R
    Vaccine; 2012 Aug; 30(40):5880-5. PubMed ID: 22771186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic profiles and antimicrobial resistance of Streptococcus pneumoniae non-PCV10 serotype isolates recovered from meningitis cases in Salvador, Brazil.
    Azevedo J; Dos Anjos ES; Cordeiro SM; Dos Santos MS; Escobar EC; Lobo PR; Carvalho MDG; Reis MG; Reis JN; Campos LC
    J Med Microbiol; 2016 Oct; 65(10):1164-1170. PubMed ID: 27599851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.
    van Hoek AJ; Sheppard CL; Andrews NJ; Waight PA; Slack MP; Harrison TG; Ladhani SN; Miller E
    Vaccine; 2014 Jul; 32(34):4349-55. PubMed ID: 24657717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population Structure of Streptococcus pneumoniae Causing Invasive Disease in Adults in Portugal before PCV13 Availability for Adults: 2008-2011.
    Horácio AN; Silva-Costa C; Diamantino-Miranda J; Lopes JP; Ramirez M; Melo-Cristino J;
    PLoS One; 2016; 11(5):e0153602. PubMed ID: 27168156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010.
    Lamb KE; Flasche S; Diggle M; Inverarity D; Greenhalgh D; Jefferies JM; Smith A; Edwards GF; Denham B; McMenamin J; McDonald E; Mitchell TJ; Clarke SC; Robertson C
    Vaccine; 2014 Jul; 32(34):4356-63. PubMed ID: 23806244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.